The No. 1 Biotech Stock to Buy for 2023 Biotech stock Vertex Pharmaceuticals (VRTX) outperformed its industry peers, gaining more than 30% over the past year. The company reported solid performance in the CF business and across the company… Previous Article 2023 is Going to be a Year of Big Retirement Changes Next Article We Are Obsessed With the Wrong Question
